[Analgesic drugs during pregnancy]

Area of Science:

• Obstetrics and Gynecology
• Pharmacology
• Neonatal Medicine

Background:

• Analgesic therapy during pregnancy presents significant challenges due to potential risks to both the mother and fetus.
• Establishing safe and effective pain management strategies is crucial throughout all stages of gestation.

Purpose of the Study:

• To review the safety and efficacy of commonly used analgesics during pregnancy.
• To provide guidance on appropriate pain management choices for pregnant individuals.

Main Methods:

• Literature review of analgesic use in pregnancy.
• Analysis of contraindications and risks associated with specific pain medications.

Main Results:

• Paracetamol is the preferred agent for mild to moderate pain in any trimester.
• Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen are contraindicated after 28 weeks due to risks of premature ductus arteriosus closure and fetal kidney dysfunction.
• Opioids carry risks of neonatal respiratory depression and withdrawal symptoms with prolonged use.
• Sumatriptan may be used for migraines, and certain antidepressants like amitriptyline can be considered for chronic pain when indicated.

Conclusions:

• Careful selection of analgesics is essential during pregnancy, balancing pain relief with fetal and neonatal safety.
• Specific medications have defined risks and contraindications that must be strictly adhered to, particularly regarding gestational age.